More about

Schizophrenia

News
May 25, 2022
1 min read
Save

Telemedicine acceptable for patients being treated for schizophrenia

Telemedicine acceptable for patients being treated for schizophrenia

NEW ORLEANS — Most investigators concluded that telemedicine is satisfactory for patients with schizophrenia being treated with long-acting injectable psychotics, according to survey results presented at the American Psychiatric Association meeting.

News
April 25, 2022
1 min read
Save

FDA approves new dosage strengths for bipolar, schizophrenia drug

FDA approves new dosage strengths for bipolar, schizophrenia drug

The FDA has granted approval to Intra-Cellular Therapies Inc. for 10.5 mg and 21 mg dosages of lumateperone to treat schizophrenia and bipolar depression, according to a company release.

News
April 20, 2022
1 min read
Save

FDA declines to move forward with schizophrenia treatment

FDA declines to move forward with schizophrenia treatment

The FDA has issued a Complete Response Letter for the New Drug Application for risperidone extended-release injectable for subcutaneous use, a schizophrenia treatment, Teva Pharmaceuticals and MedinCell announced in a statement.

News
April 12, 2022
1 min read
Save

Virtual reality treatment shows success in those with schizophrenia, mood disorders

Virtual reality treatment shows success in those with schizophrenia, mood disorders

OxfordVR has announced a successful new virtual reality therapy for patients with mental illnesses such as schizophrenia and mood disorders with psychotic symptoms.

News
April 06, 2022
1 min read
Save

FDA approves sublingual treatment for agitation

FDA approves sublingual treatment for agitation

BioXcel Therapeutics has announced the FDA approval of Igalmi, a sublingual film for acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

News
April 05, 2022
1 min read
Save

Those with schizophrenia less likely to get COVID-19 booster

People with schizophrenia were less likely to have received a COVID-19 booster, while gaps in acquisition were greatest for the first vaccination, according to a retrospective cohort study published in JAMA Psychiatry.

News
March 09, 2022
3 min read
Save

Serious mental illness tied to elevated CV risk; uncontrolled risk factors prevalent

Serious mental illness tied to elevated CV risk; uncontrolled risk factors prevalent

Individuals with serious mental illnesses such as bipolar disorder and schizophrenia may experience greater 10- and 30-year CV risk compared with those without a serious mental illness, researchers reported.

News
February 11, 2022
1 min read
Save

Lybalvi for schizophrenia, bipolar disorder shows positive phase 3b results

Alkermes announced positive topline results from its phase 3b study of Lybalvi in young adults with schizophrenia, schizophreniform disorder or bipolar I disorder who were early in their illness.

News
February 08, 2022
1 min read
Save

3-monthly paliperidone treatment reduced hospitalization in patients with schizophrenia

3-monthly paliperidone treatment reduced hospitalization in patients with schizophrenia

Patients with schizophrenia who were treated with 3-monthly paliperidone in a clinical setting required rehospitalization less often, according to a 5-year U.K. mirror image study published in the Journal of Psychiatric Research.

News
January 28, 2022
1 min read
Save

Top psych stories of January: Global impact of mental disorders, support for psychedelics

Healio’s most-viewed psychiatry stories in January highlight the global burden of mental disorders on health, a survey that provides insights into Americans’ support of psychedelics and a regulatory development for Rexulti.

View more